Corporate Luncheon Workshops

The Corporate Luncheon Workshops are independent from the ISLH educational content and are non-CME. Please review the available workshops below and pre-register for any workshops that you wish to attend. There is no cost to attend these workshops. Corporate luncheon workshops are limited to meeting attendees.

How to Register

If you have already registered for the conference
You may access the workshop registration system by logging into Your Account and clicking on the"Register Now" link in the corporate lunch column in your conference registration record.

If you have not yet registered for the conference
Please REGISTER HERE to first submit your conference registration. You will then be able to register for a luncheon workshop.

Please email us at with any questions



Beckman Coulter

Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters

& Implementing An Evolving Automated Laboratory

Friday, May 10, 2013 12:00PM - 1:45PM - Civic Ballroom South

Automated screening for myelodysplastic syndromes through analysis of complete blood count and cell population data parameters

Gerald B. Wertheim, MD, PhD
Assistant Professor of Pathology and Laboratory Medicine at the Children's Hospital of Philadelphia

Program Overview:
The diagnosis of myelodysplastic syndromes (MDS) requires a high index of  clinical suspicion and subjective assessment of dysplastic morphologic features.  Previous studies showed how the leucocyte morphologic parameters collectively known as "Cell Population Data" (CPD) identified MDS in selected patient populations.

We will introduce a multi-parametric model developed using step-wise linear regression that automatically identified patients with MDS based on age, reported CBC parameters, and CPD data, in an unselected routine outpatient population (>5000 patients collected over 6 months). The main advantages and limitations of using hematology analyzers for automated screening of myelodysplasia will be discussed.

Implementing An Evolving Automated Laboratory

Shawn Cotton BSc FABMS CSci CMS
Laboratory Manager
Kingston Hospital NHS Trust, London, UK.

Program Overview:
Kingston Hospitals NHS Trust is the largest single site District General Hospital in London. In recent years it had to cope with a rapidly expanding workload and decreasing government funding for laboratory medicine.

This transformation was possible thanks to a partnership with Beckman Coulter to maintain service standards.

The primary objectives for this partnership  were:
• standardisation of workflow
• reduction in time wasting and manual steps
• improved and consistent turn-around time (TAT)
• ongoing training and staff support

Information technology systems were updated with Remisol Advance and we installed the Unicel DxH 800 Series haematology platform to deliver more precise and faster analysis, along with Beckman Coulter Automate 1200 Series peri-analytical workstation to automate sample sorting and archiving.

These improvements changed how staff manages the workflow, releasing them from manual processes.


Digital Cell Morphology - User experiences in Pathology, Proficiency and Connectivity

Friday, May 10, 2013 12:00PM - 1:45PM - Dominion South

CellaVision systems, software and services are rapidly becoming the new standard in automated digital cell morphology in thousands of labs around the world. In this workshop you will learn about the experiences of Memorial Sloan-Kettering Cancer Center (New York, NY), University Health Network (Toronto, ON) and The University of North Carolina Healthcare System (Chapel Hill, NC), and what they have been able to achieve in their organizations by incorporating digital cell morphology into their laboratory operations.

Program Overview: 
•  Use of a new, cloud-based proficiency service for blood and body fluid morphology, and its impact on the training and testing of a large staff at Memorial Sloan-Kettering
• How University Health Network has improved the efficiency and standardization of differential analysis across multiple facilities of all sizes, including small labs
• Preliminary findings from a clinical study conducted at UNC Healthcare System which asked the question, “Can the Pathology review of images from the CellaVision DM96 replace the review of the blood film using the glass slide”
• Memorial Sloan-Kettering also will present on the use of the CellaVision DM96 in the sub classification of variant lymphocyte populations in chronic lymphocytic leukemia

Steven Marionneaux, MS, MT(ASCP)
Manager, Clinical Hematology Laboratories, Memorial Sloan-Kettering Cancer Center, New York, NY
Assistant Adjunct Professor, University of Medicine and Dentistry of New Jersey
Instructor of Medicine, New York Medical College

Stephanie Mathews, M.D.
Assistant Professor of Pathology and Laboratory Medicine
Director of Analytical Hematology
University of North Carolina at Chapel Hill

Marni Lollo   MLT, ART
Manager Core Laboratory Services and Rapid Response
Laboratory Medicine Program
University Health Network

Ivana Vidovic MLT
Laboratory Medicine Program
University Health Network



Shaping the Future of Hematology

Friday, May 10, 2013 12:00PM - 1:45PM - Dominion North

Program Overview:
In today’s changing healthcare environment, there is increasing pressure to justify cost, provide more for less and to improve the quality of healthcare and therapy decisions. The development of immature cell indices that can provide useful information about the pathophysiologic mechanism of hematopoiesis to the clinican to help guide and justify treatment decisions is becoming more important. This year’s event will be focused on the clinical utility of two immature cell indices, the automated Immature Granulocyte Count and the Immature Platelet Fraction.

The Sysmex Immature Granulocyte Marker: Reference Ranges and Clinical Use in Outpatient Settings
Michael H. A. Roehrl, M.D., Ph.D.
Director, UHN Program in BioSpecimen Sciences, Toronto, Canada.

The Clinical Utility of the Immature Platelet Fraction
Alan D. Michelson, M.D.
Professor of Pediatrics and Professor of Medicine, Harvard Medical School
Director, Center for Platelet Research Studies, Boston Children’s Hospital/Dana-Farber Cancer Institute, Boston, MA

Mechanism of Thrombocytopenia in Chronic Hepatitis C as Evaluated by the Immature Platelet Fraction
Marjorie L. Zucker, M.D.
Formerly Assoc. Professor of Pathology, Kansas University Medical Center, Kansas City, KS





An Image-Based CBC Solution for Near-Patient Care & An Introduction to Human Factors and Its Role in the Development of Next Generation Hematology Instrumentation

SATURDAY, MAY 11, 2013 12:00PM - 1:45PM - Dominion North

Please contact your Abbott representative or to request an invitation.

An Image-Based CBC Solution for Near-Patient Care

Program Overview:
The rapid advancement of technology has made it increasingly possible to provide critical diagnostic tests at the point of patient care (POC).  Instead of waiting for test results for hours or even days, clinicians can perform diagnostic tests in minutes while the patient is present.  This is especially important in situations where rapid test turnaround is essential for positive patient outcomes.  While POC tests are increasingly available, there are as yet no satisfactory complete blood count (CBC) and white blood cell (WBC) differential solutions for near patient testing. Various hematology solutions based on automated impedance and flow cytometry or other traditional technologies have been developed, but none of them fully satisfy the demand for rapid, accurate sample analysis, fluid-free processing, reliability, compactness, low cost and ease of operation. All of these are important requirements for POC diagnostic systems.  We report on a new technology for POC hematology testing that makes use of digital imaging to produce a CBC and a five-part WBC differential. Dr Herzog is a research scientist with the Abbott Point of Care division

Speaker: David P Herzog PhD, Abbott Laboratories

 An Introduction to Human Factors and Its Role in the Development of Next Generation Hematology Instrumentation

Program Overview:
Products are often designed in ways that are not compatible with the humans that use them. Such products, including medical devices are often difficult to use and sometimes contribute to human errors that prevent these devices from fulfilling their intended function. Human factors is a discipline that applies information regarding human abilities, limitations and characteristics to the design of tools, machines, systems, tasks, jobs, and environments for safe, comfortable, and effective human use. The current presentation will begin with a brief overview of human factors and will present a case study of human factors in the early development of a future hematology instrument. Dr Muto is research scientist working on the development of Abbott’s next generation instruments

Speaker: William H Muto PhD, Abbott Laboratories



SATURDAY, MAY 11, 2013 12:00PM - 1:45PM - Civic Ballroom South

Moderator: Cornelis Harteveld

No substantial innovations have arisen recently in the field of hemoglobinopathies diagnosis. This diagnosis relies primarily on separation and accurate quantification of hemoglobin A2, F and variants.

By attending this workshop you will learn how the new Sebia Capillarys HbA1c assay has become an indirect but strong medical added value for the mass screening of hemoglobin disorders. Lecture by Ross Molinaro (Emory University Hospital, Atlanta US) will show how the high resolution separation and the accurate quantitation of HbA2 offered Capillarys HbA1c assay allow for the incidental detection of hemoglobinopathies and thalassemia during the follow-up/diagnosis of diabetic patients, thus providing precious information to his colleague Hematologist. You will also learn how a pioneer, Andrew Mc Farlane (Hamilton Regional Laboratory Medicine Program, Hamilton, Canada) has made the choice of Capillarys Hemoglobin as his primary hemoglobinopathy screening method. He will share with the audience his long experience with CAPILLARYS 2 Flex Piercing and expose all benefits brought by this technology for the diagnosis of hemoglobin disorders through a case-based approach.

Finally in the field of Thalassemia diagnosis, Sebia recent partner of the INSERM U779 (Institut National de la Sante et de la Recherche Medicale, France) for the development of a unique assay for the quantification of the free alpha hemoglobin chains will open the dialogue with the audience, in order to evaluate the potential use of this assay in specialized laboratories (Marie-Thérèse Melki, Sebia).

Ross Molinaro (Emory University Hospital, Atlanta US)

Andrew Mc Farlane (Hamilton Regional Laboratory Medicine Program, Hamilton, Canada)

Marie-Thérèse Melki, Sebia



Platelet Morphology and Coagulation Activation Markers: Diagnostic Utility in Hemostatic Disorders

SATURDAY, MAY 11, 2013 12:00PM - 1:45PM - Dominion South

Dr. Steve Kitchen
Clinical Scientist, Department of Coagulation
Royal Hallamshire Hospital
Sheffield, UK

Clinical and laboratory approach to disseminated intravascular coagulopathy in different clinical scenarios and the role of D-dimer
Professor Alhossain A. Khalafallah
Consultant Hematologist, School of Human Life Sciences
The Launceston General Hospital, Tasmania

Program Overview:
Disseminated intravascular coagulation (DIC) is a serious complication of many clinical scenarios including infection/sepsis, malignancy, and trauma or surgery. DIC remains a clinical diagnosis supported by laboratory data.

In the diagnosis of DIC, there are several key contributing factors, including:
- DIC scoring system introduced by the ISTH/SSC, including platelet count, PT, fibrinogen and D-dimer levels
- The role of D-dimer as the key marker for diagnosis and prognosis
- Diagnostics criteria, D-dimer sensitivity, and negative predictive value
In addition, the speaker will share relevant experience with the INNOVANCE® D-Dimer assay in a single center prospective study.

Platelet parameters and morphology investigation: where these can help in diagnosing platelet disorders
Dr. Veronique Latger- Cannard
Medical Biologist, Biological Hematology Service
University Hospital of Nancy, Vandoeuvre-Les-Nancy, France
North-East Competence Center of Platelet Disorders, France

Program Overview:
Inherited thrombocytopenias (IT) are heterogeneous disorders affecting platelet count and function.  Distinguishing IT from immune thrombocytopenia (ITP) is a practical challenge, and therefore, patients are at risk of misdiagnosis and inappropriate treatment such as administration of intravenous steroids, immunoglobulins and/or needless splenectomy. Diagnostic difficulties reported in literature will be illustrated by clinical cases from the speaker’s individual experience. 

Areas of interest in the diagnosis of IT include:
- Platelet size and morphology analysis.
- MPV values—differences between hematology analyzers
- The role of MPV, PCT, PDW, MPC, PCDW, MPM, and PMDW
- Specific platelet phenotype and algorithms based on the platelet parameter assessment 


International Society For Laboratory Hematology
Phone: 847.983.3519

2111 Chestnut Ave, Suite 145 | Glenview, IL 60025 | USA